Clinical trial Recruiting at 4 sites Interventional Ages 18 and up Women only

Using negative pressure therapy to prevent complications after complex breast cancer surgery

Official title: Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery: a Prospective Randomized Controlled Trial

Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT06265558 · Data updated 2026-11-12

This study is testing if negative pressure therapy can help women recover better and avoid complications after complex breast cancer surgeries.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment254 (estimated)
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations7 sites (Dijon, Côte d'Or and 6 other locations)
StatusRecruiting
StartedApril 15, 2025
Main results expectedMay 2027
Study endsJuly 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT06265558 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 and older with unilateral invasive or in situ breast carcinoma who are undergoing complex breast surgery and have at least one risk factor for scarring disorders.

Probably not a fit

Patients who do not have any of the specified risk factors for scarring disorders or those with legal incapacity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of negative pressure therapy (NPT) in reducing postoperative complications following complex breast cancer surgeries, such as mastectomy with immediate breast reconstruction. The study aims to address the high rates of surgical wound complications, which can significantly impact patient recovery and quality of life. By enrolling female patients with specific risk factors for scarring disorders, the trial will assess the outcomes of NPT compared to standard care. The methodology includes monitoring complication rates and patient satisfaction post-surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery for breast cancer patients undergoing complex surgeries.

How similar studies have gone: While there have been a few retrospective studies on negative pressure therapy in breast surgery, this trial aims to provide more robust evidence through a prospective approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female ≥ 18 years
2. Patient with unilateral invasive or in situ breast carcinoma
3. Patient with or without neoadjuvant treatment
4. Patient presenting an indication for complex breast surgery by mastectomy with immediate breast reconstruction by implant or oncoplasty by T-shaped mammoplasty.
5. Patient presenting at least one of the following risk factors for scarring disorders:

   * Obesity with Body Mass Index BMI ≥ 30 and/or Cup size ≥ E
   * Active smoking or smoking cessation for less than one month
   * Diabetes
   * History of homolateral breast radiotherapy
   * Long-term corticosteroid therapy
6. Patient to have signed informed consent prior to study entry
7. Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures.
8. Patient affiliated with a health insurance plan.

Exclusion Criteria:

1. Legal incapacity or limited legal capacity. Medical or psychological conditions preventing the patient from completing the study or signing the consent form.
2. Pregnant or breast-feeding patient as determined in medical records as part of standard patients care and follow-up
3. Patient under guardianship or safeguard of justice
4. Patient participating in an interventional study with the objective of wound healing
5. Any concurrent or planned surgical procedure on the contralateral breast

Where it's running

  • Centre Hospitalier de Nîmes
    Nîmes, Gard, France
    Recruiting
  • Centre Hospitalier de Montpellier
    Montpellier, Hérault, France
    Recruiting
  • Institut régional du Cancer de Montpellier
    Montpellier, Hérault, France
    Recruiting
  • Institut de Cancérologie de l'Ouest
    Angers, Maine Et Loire, France
    Recruiting
  • Centre Georges-François Leclerc
    Dijon, Côte d'Or, France
    Not yet recruiting
  • Institut Bergonié
    Bordeaux, Gironde, France
    Not yet recruiting
Show 1 more location
  • Centre Léon Bérard
    Lyon, Rhône, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.